Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Viral infections and antiphospholipid antibodies

Uthman, I. W., & Gharavi, A. E. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.28303 · Cited by 302

Cerebrovascular Disease in COVID-19

Goldberg, M. F., Goldberg, M. F., Cerejo, R., & Tayal, A. H. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6588 · Cited by 126

Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review

Seirafianpour, F., Sodagar, S., Mohammad, A. P., Panahi, P., Mozafarpoor, S., Almasi, S., & Goodarzi, A. (2020) · Dermatologic Therapy · doi:10.1111/dth.13986 · Cited by 125

Covid-19-Associated Retinopathy: A Case Report

Gascon, P., Briantais, A., Bertrand, E., Ramtohul, P., Comet, A., Beylerian, M., Sauvan, L., Swiader, L., Durand, J. M., & Denis, D. (2020) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2020.1825751 · Cited by 129

COVID-19 and the clinical course of rheumatic manifestations

Ahmed, S., Zimba, O., & Gasparyan, A. Y. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05691-x · Cited by 131

Complement in Secondary Thrombotic Microangiopathy

Palma, L. M. P., Sridharan, M. R., & Sethi, S. M. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.10.009 · Cited by 124

COVID-19 convalescent plasma composition and immunological effects in severe patients

Acosta‐Ampudia, Y., Monsalve, D. M., Rojas, M., Rodríguez, Y., Gallo, J. E., Salazar-Uribe, J. C., Santander, M. J., Cala, M. P., Zapata, W., Zapata-Cardona, M. I., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102598 · Cited by 126

Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

Valle, F. G., Oblitas, C., Jenaro, M. M. F.-M., Muñoz, J. A., del Toro‐Cervera, J., Natale, M. D., & Rodríguez, P. D. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.017 · Cited by 124

COVID-19 Sepsis and Microcirculation Dysfunction

Colantuoni, A., Martini, R., Caprari, P., Ballestri, M., Capecchi, P. L., Gnasso, A., Presti, R. L., Marcoccia, A., Rossi, M., & Caimi, G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00747 · Cited by 130

The Australian Institute of Sport framework for rebooting sport in a COVID-19 environment

Hughes, D. C., Saw, R., Perera, N. K. P., Mooney, M., Wallett, A. M., Cooke, J., Coatsworth, N. R., & Broderick, C. R. (2020) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2020.05.004 · Cited by 136

Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries

Liu, J., Zhang, L., Yan, Y., Zhou, Y., Yin, P., Qi, J., Wang, L., Pan, J., You, J., Yang, J., et al. (2021) · BMJ · doi:10.1136/bmj.n415 · Cited by 122

Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?

Bianconi, V., Violi, F., Fallarino, F., Pignatelli, P., Sahebkar, A., & Pirro, M. (2020) · Drugs · doi:10.1007/s40265-020-01365-1 · Cited by 124

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13

Yang, J., Wu, Z., Long, Q., Huang, J., Hong, T., Liu, W., & Lin, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610696 · Cited by 128

A current review of COVID-19 for the cardiovascular specialist

Lang, J. P., Wang, X., Moura, F. A., Siddiqi, H. K., Morrow, D. A., & Bohula, E. A. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.04.025 · Cited by 120

Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke

Xu, Q., Zhao, B., Ye, Y., Li, Y., Zhang, Y., Xiong, X., & Gu, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02137-8 · Cited by 119

Neurological involvement of coronavirus disease 2019: a systematic review

Ghannam, M., Alshaer, Q., Al-Chalabi, M., Zakarna, L., Robertson, J., & Manousakis, G. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09990-2 · Cited by 119

Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis

Rossotti, R., Travi, G., Ughi, N., Corradin, M., Baiguera, C., Fumagalli, R., Bottiroli, M., Mondino, M. G., Merli, M., Bellone, A., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.07.008 · Cited by 119

Stroke as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes and predictors

Siow, I., Lee, K. S., Zhang, J. J. Y., Saffari, S. E., Ng, A., & Young, B. (2021) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.105549 · Cited by 116

High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia

Gazzaruso, C., Carlo-Stella, N., Mariani, G., Nai, C., Coppola, A., Naldani, D., & Gallotti, P. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05180-7 · Cited by 116

The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges

Tundo, G. R., Sbardella, D., Santoro, A. M., Coletta, A., Oddone, F., Grasso, G., Milardi, D., Lacal, P. M., Marini, S., Purrello, R., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107579 · Cited by 120

Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation

Fraser, D. D., Patterson, E. K., Slessarev, M., Gill, S. E., Martin, C. M., Daley, M., Miller, M. R., Patel, M. A., dos Santos, C. C., Bosma, K. J., et al. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000194 · Cited by 117

Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review

Tu, T. M., Goh, C., Tan, Y. K., Leow, A. S., Pang, Y., Chien, J. M.-F., Shafi, H., Chan, B., Hui, A. C.-F., Koh, J. S., et al. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.105379 · Cited by 115

Insulin resistance in COVID-19 and diabetes

Govender, N., Khaliq, O. P., Moodley, J., & Naicker, T. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.04.004 · Cited by 120

Vaccinations and Autoimmune Diseases

Olivieri, B., Betterle, C., & Zanoni, G. (2021) · Vaccines · doi:10.3390/vaccines9080815 · Cited by 120

COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes

Bigdelou, B., Sepand, M. R., Najafikhoshnoo, S., Negrete, J. A. T., Sharaf, M., Ho, J. Q., Sullivan, I., Chauhan, P. S., Etter, M. M., Shekarian, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890517 · Cited by 126

The looming storm: Blood and cytokines in COVID-19

Kaur, S., Bansal, R., Kollimuttathuillam, S., Gowda, A. M., Singh, B., Mehta, D., & Maroules, M. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100743 · Cited by 113

Is COVID-19 a New Hematologic Disease?

Debuc, B., & Smadja, D. M. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09987-4 · Cited by 112

Pathogenesis, Clinical Manifestations and Complications of COVID-19

Kordzadeh-Kermani, E., Khalili, H., & Karimzadeh, I. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0110 · Cited by 121

Coronavirus Disease 2019–Associated Coagulopathy

Lippi, G., Sanchis‐Gomar, F., Favaloro, E. J., Lavie, C. J., & Henry, B. M. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.10.031 · Cited by 110

“Neurological manifestations of COVID-19” - guideline of the German society of neurology

Berlit, P., Bösel, J., Gahn, G., Isenmann, S., Meuth, S. G., Nolte, C. H., Pawlitzki, M., Rosenow, F., Schoser, B. G. H., Thomalla, G., et al. (2020) · Neurological Research and Practice · doi:10.1186/s42466-020-00097-7 · Cited by 115

Extrapulmonary and atypical clinical presentations of COVID‐19

Abobaker, A., Raba, A. A., & Alzwi, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26157 · Cited by 110

COVID-19: from epidemiology to treatment

Pericàs, J. M., Meneses, M. H., Sheahan, T. P., Quintana, E., Ambrosioni, J., Sandoval, E., Falces, C., Marcos, M. Á., Tuset, M., Vilella, A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa462 · Cited by 110

Rheumatological complications of Covid 19

Zacharias, H., Dubey, S., Koduri, G., & D’Cruz, D. P. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102883 · Cited by 118

The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19

Basile, M. S., Cavalli, E., McCubrey, J. A., Hernández‐Bello, J., Muñóz-Valle, J. F., Fagone, P., & Nicoletti, F. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.002 · Cited by 114

The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals

Cañas, C. A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110345 · Cited by 116

COVID-19 and cerebrovascular diseases: a comprehensive overview

Tsivgoulis, G. K., Palaiodimou, L., Zand, R., Lioutas, V., Krogias, C., Katsanos, A. H., Shoamanesh, A., Sharma, V. K., Shahjouei, S., Baracchini, C., et al. (2020) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286420978004 · Cited by 112

Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review

Taha, M., & Samavati, L. (2021) · RMD Open · doi:10.1136/rmdopen-2021-001580 · Cited by 109

Chronic Kidney Disease as a Systemic Inflammatory Syndrome: Update on Mechanisms Involved and Potential Treatment

Tinti, F., Lai, S., Noce, A., Rotondi, S., Marrone, G., Mazzaferro, S., Daniele, N. D., & Mitterhofer, A. P. (2021) · Life · doi:10.3390/life11050419 · Cited by 117

Central retinal vein occlusion with COVID-19 infection as the presumptive etiology

Makhija, S., Walinjkar, J. A., Sharma, H., Morekar, S., & Natarajan, S. (2020) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2575_20 · Cited by 108

Hematologic disorders associated with COVID-19: a review

Rahi, M. S., Jindal, V., REYES, S. L. P., Gunasekaran, K., Gupta, R., & Jaiyesimi, I. A. (2021) · Annals of Hematology · doi:10.1007/s00277-020-04366-y · Cited by 117

Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications

Chaturvedi, S., Braunstein, E. M., & Brodsky, R. A. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15082 · Cited by 109

Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis

Cardinale, V., Capurso, G., Ianiro, G., Gasbarrini, A., Arcidiacono, P. G., & Alvaro, D. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.09.009 · Cited by 107

Clustered cases of acral perniosis: Clinical features, histopathology, and relationship to COVID‐19

Cordoro, K. M., Reynolds, S. D., Wattier, R. L., & McCalmont, T. H. (2020) · Pediatric Dermatology · doi:10.1111/pde.14227 · Cited by 106

Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study

Shahjouei, S., Naderi, S., Li, J., Khan, A., Chaudhary, D. P., Farahmand, G., Male, S., Griessenauer, C. J., Sabra, M., Mondello, S., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102939 · Cited by 106

Rheumatic manifestations of COVID-19: a systematic review and meta-analysis

Ciaffi, J., Melicòni, R., Ruscitti, P., Berardicurti, O., Giacomelli, R., & Ursini, F. (2020) · BMC Rheumatology · doi:10.1186/s41927-020-00165-0 · Cited by 106

Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series

Reddy, S. T., Garg, T., Shah, C., Nascimento, F. A., Imran, R., Kan, P. T. M., Bowry, R., Gonzales, N. R., Barreto, A. D., Kumar, A., et al. (2020) · Case Reports in Neurology · doi:10.1159/000508958 · Cited by 107

COVID-19 Related Coagulopathy: A Distinct Entity?

Marchandot, B., Sattler, L., Jesel, L., Matsushita, K., Schini‐Kerth, V. B., Grunebaum, L., & Morel, O. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061651 · Cited by 105

Hemostatic laboratory derangements in COVID-19 with a focus on platelet count

Amgalan, A., & Othman, M. (2020) · Platelets · doi:10.1080/09537104.2020.1768523 · Cited by 104

Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis

Länger, F. P., Kluge, S., Klamroth, R., & Oldenburg, J. (2020) · Hämostaseologie · doi:10.1055/a-1178-3551 · Cited by 104

Kidney Infarction in Patients With COVID-19

Post, A., den Deurwaarder, E., Bakker, S. J. L., de Haas, R. J., van Meurs, M., Gansevoort, R. T., & Berger, S. P. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.004 · Cited by 102

Brain Imaging of Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak in New York City

Lin, E., Lantos, J. E., Strauß, S., Phillips, C. D., Campion, T. R., Navi, B. B., Parikh, N. S., Merkler, A. E., Mir, S. A., Zhang, C., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6793 · Cited by 105

COVID‐19 and ischemic stroke

Sagris, D., Papanikolaou, A., Kvernland, A., Korompoki, E., Frontera, J. A., Troxel, A. B., Gavriatopoulou, M., Milionis, H. J., Lip, G. Y. H., Michel, P., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15008 · Cited by 106

Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction

Blasco, A., Coronado, M. J., Terciado, F. H., Martín, P., Royuela, A., Ramil, E., García, D., Goicolea, J., Trigo, M. D., Ortega, J., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.7308 · Cited by 101

SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities

Alam, M. S., & Czajkowsky, D. M. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.11.001 · Cited by 111

COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications

Yamamoto, V., Bolanos, J. F., Fiallos, J., Strand, S. E., Morris, K., Shahrokhinia, S., Cushing, T. R., Hopp, L., Tiwari, A., Hariri, R., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200831 · Cited by 100

Emergency room neurology in times of COVID‐19: malignant ischaemic stroke and SARS‐CoV‐2 infection

González, T. G.-P., Rodríguez, A. L., Estébanez, A. M., Agirre-Beitia, G., Rodríguez-Antigüedad, A., & Ruíz-López, M. (2020) · European Journal of Neurology · doi:10.1111/ene.14286 · Cited by 100

COVID-19, coagulopathy and venous thromboembolism: more questions than answers

Marietta, M., Coluccio, V., & Luppi, M. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02432-x · Cited by 100

Does COVID‐19 contribute to development of neurological disease?

Mahalakshmi, A. M., Ray, B., Tuladhar, S., Bhat, A., Paneyala, S., Patteswari, D., Sakharkar, M. K., Hamdan, H., Ojcius, D. M., Bolla, S. R., et al. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.387 · Cited by 100

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?

Valencia, I., Peiró, C., Lorenzo, Ó., Sánchez‐Ferrer, C. F., Eckel, J., & Romacho, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01161 · Cited by 100

Current Status of COVID-19 Therapies and Drug Repositioning Applications

Altay, O., Mohammadi, E., Lam, S., Turkez, H., Boren, J., Nielsen, J., Uhlen, M., & Mardinoglu, A. (2020) · iScience · doi:10.1016/j.isci.2020.101303 · Cited by 98

Cerebral venous thrombosis: Atypical presentation of COVID-19 in the young

Klein, D. E., Libman, R., Kirsch, C., & Arora, R. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104989 · Cited by 98

Pediatric Ischemic Stroke: An Infrequent Complication of SARS‐CoV ‐2

Beslow, L. A., Linds, A. B., Fox, C. K., Kossorotoff, M., Zambrano, Y. C. Z., Hernández, M., Hassanein, S. M. A., Byrne, S., Lim, M. J., Maduaka, N., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25991 · Cited by 99

The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature

Novelli, L., Motta, F., Santis, M. D., Ansari, A. A., Gershwin, M. E., & Selmi, C. F. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102592 · Cited by 100

Using Automated Machine Learning to Predict the Mortality of Patients With COVID-19: Prediction Model Development Study

Ikemura, K., Bellin, E. Y., Yagi, Y., Billett, H. H., Saada, M., Simone, K., Stahl, L., Szymanski, J. M., Goldstein, D. Y., & Gil, M. R. (2021) · Journal of Medical Internet Research · doi:10.2196/23458 · Cited by 99

Neurological manifestations and neuro‐invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2

Vonck, K. E. J., Garrez, I., Herdt, V. D., Hemelsoet, D., Laureys, G., Raedt, R., & Boon, P. (2020) · European Journal of Neurology · doi:10.1111/ene.14329 · Cited by 99

Coronavirus disease 2019 in chronic kidney disease

D’Marco, L., Puchades, M. J., Romero-Parra, M., Giménez-Civera, E., Soler, M. J., Ortíz, A., & Górriz, J. L. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa104 · Cited by 97

COVID‐19 as a Blood Clotting Disorder Masquerading as a Respiratory Illness: A Cerebrovascular Perspective and Therapeutic Implications for Stroke Thrombectomy

Janardhan, V., Janardhan, V., & Kalousek, V. (2020) · Journal of Neuroimaging · doi:10.1111/jon.12770 · Cited by 95

Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19

Bautista-Vargas, M. A., Bonilla‐Abadía, F., & Cañas, C. A. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02172-x · Cited by 97

Thromboembolic events and Covid-19

Ribes, A. M., Bounes, F. V., Mémier, V., Poette, M., Au-Duong, J., Garcia, C., Minville, V., Siè, P., Bura-Rivière, A., Voisin, S., et al. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100735 · Cited by 97

Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US

Fung, K. W., Baye, F. M., Baik, S. H., Zheng, Z., & McDonald, C. J. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004194 · Cited by 105

Viral Coagulopathy in Patients With COVID-19: Treatment and Care

Kipshidze, N., Dangas, G., White, C. J., Kipshidze, N. N., Siddiqui, F., Lattimer, C. R., Carter, C. A., & Fareed, J. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620936776 · Cited by 98

Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications

Revzin, M. V., Raza, S., Warshawsky, R., D’Agostino, C. A., Srivastava, N. C., Bader, A. S., Malhotra, A., Patel, R. D., Chen, K., Kyriakakos, C., et al. (2020) · Radiographics · doi:10.1148/rg.2020200149 · Cited by 103

Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men

Tu, T. M., Seet, C. Y. H., Koh, J. S., Tham, C. H., Chiew, H. J., Angon, J., Chua, C. Y. K., Hui, A. C.-F., Tan, S. S. Y., Vasoo, S. S., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.7498 · Cited by 95

Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations

Flaczyk, A., Rosovsky, R. P. G., Reed, C. T., Bankhead-Kendall, B., Bittner, E. A., & Chang, M. G. (2020) · Critical Care · doi:10.1186/s13054-020-03273-y · Cited by 95

Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?

Zizzo, G., & Cohen, P. L. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30340-4 · Cited by 99

COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review)

Zhang, S., Zhang, J., Wang, C., Chen, X., Zhao, X., Jing, H., Liu, H., Li, Z., Wang, L., & Shi, J. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4854 · Cited by 99

Acute aorto‐iliac and mesenteric arterial thromboses as presenting features of COVID‐19

Vulliamy, P., Jacob, S., & Davenport, R. A. (2020) · British Journal of Haematology · doi:10.1111/bjh.16760 · Cited by 93

Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection

Viguier, A., Delamarre, L., Duplantier, J., Olivot, J., & Bonneville, F. (2020) · Journal of Neuroradiology · doi:10.1016/j.neurad.2020.04.003 · Cited by 93

Hematological manifestations of SARS‐CoV‐2 in children

Kosmeri, C., Koumpis, E., Tsabouri, S., Siomou, E. C., & Makis, A. C. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28745 · Cited by 96

Association of anticoagulation dose and survival in hospitalized COVID‐19 patients: A retrospective propensity score‐weighted analysis

Ionescu, F., Jaiyesimi, I. A., Petrescu, I., Lawler, P. R., Castillo, E. M., Maldonado, Y. M., Imam, Z., Narasimhan, M., Abbas, A. E., Konde, A. S., et al. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13533 · Cited by 93

Optical Coherence Tomography Angiography Features in Post-COVID-19 Pneumonia Patients: A Pilot Study

Cennamo, G., Reibaldi, M., Montorio, D., D’Andrea, L., Fallico, M., & Triassi, M. (2021) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2021.03.015 · Cited by 96

Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban

Dumitrașcu, O., Volod, O., Bose, S., Wang, Y., Biousse, V., & Lyden, P. D. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104982 · Cited by 92

High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?

de Chambrun, M. P., Frère, C., Miyara, M., Amoura, Z., Martin‐Toutain, I., Mathian, A., Hékimian, G., & Combes, A. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13126 · Cited by 92

COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness

Du, F., Liu, B., & Zhang, S. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02224-2 · Cited by 92

Non-respiratory presentations of COVID-19, a clinical review

Alsamman, M., Caggiula, A., Ganguli, S., Misak, M., & Pourmand, A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.054 · Cited by 93

Venous Thromboembolism in COVID-19

Schulman, S., Hu, Y., & Konstantinides, S. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1718532 · Cited by 92

COVID-19 and thrombotic microangiopathies

Tiwari, N. R., Phatak, S. B., Sharma, V. R., & Agarwal, S. K. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.04.012 · Cited by 93

Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines

Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., Chen, W., Zhang, H., Liu, Q., Zhu, R., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00329-3 · Cited by 96

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients

Bazzan, M., Montaruli, B., Sciascia, S., Cosseddu, D., Norbiato, C., & Roccatello, D. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02394-0 · Cited by 91

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

Kruse, J. M., Magomedov, A., Kurreck, A., Münch, F. H., Koerner, R., Kamhieh‐Milz, J., Kahl, A., Gotthardt, I., Piper, S. K., Eckardt, K., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03401-8 · Cited by 91

Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection

Cheung, S., Quiwa, J. C., Pillai, A., Onwu, C., Tharayil, Z. J., & Gupta, R. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.925753 · Cited by 90

Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study

Fan, S., Xiao, M., Han, F., Xia, P., Bai, X., Chen, H., Zhang, H., Ding, X., Zhao, H., Zhao, J., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00806 · Cited by 89

The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness

Coopersmith, C. M., Antonelli, M. M., Bauer, S. R., Deutschman, C. S., Evans, L., Ferrer, R., Hellman, J., Jog, S., Kesecioğlu, J., Kissoon, N. “., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004895 · Cited by 99

VTE in ICU Patients With COVID-19

Moll, M. R., Zon, R. L., Sylvester, K. W., Chen, E. C., Cheng, V., Connell, N. T., Fredenburgh, L. E., Baron, R. M., Cho, M. H., Woolley, A. E., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.07.031 · Cited by 89

Association of Coronavirus Disease (COVID-19) With Large Vessel Occlusion Strokes: A Case-Control Study

Kihira, S., Schefflein, J., Mahmoudi, K., Rigney, B., Delman, B. N., Mocco, J., Doshi, A. H., & Belani, P. B. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.23847 · Cited by 89

Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies

Ali, O. H., Bomze, D., Risch, L., Brugger, S. D., Paprotny, M., Weber, M. C., Thiel, S. L., Kern, L., Albrich, W. C., Kohler, P. P., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1496 · Cited by 89

Knowledge, attitudes, and practices of the general population about Coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis with policy recommendations

Saadatjoo, S. A., Miri, M., Hassanipour, S., Ameri, H., & Arab‐Zozani, M. (2021) · Public Health · doi:10.1016/j.puhe.2021.03.005 · Cited by 93

Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study

Zdravković, M., Berger‐Estilita, J., Zdravković, B., & Berger, D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241826 · Cited by 86

Acute Cerebrovascular Events With COVID-19 Infection

Dhamoon, M. S., Thaler, A. I., Gururangan, K., Kohli, A., Sisniega, D. C., Wheelwright, D., Mensching, C., Fifi, J. T., Fara, M. G., Jetté, N., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.031668 · Cited by 87

Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications

Liu, J., Zhang, X., & Cao, X. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102856 · Cited by 90

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?

Siguret, V., Voicu, S., Neuwirth, M., Delrue, M., Gayat, É., Stépanian, A., & Mégarbane, B. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.07.016 · Cited by 87

ANTIPHOSPHOLIPID-LIKE SYNDROME INDUCED BY COVID19: A CASE REPORT STUDY

Marinkovic, S. P., Anastasovski, A., & Todorovska, L. (2024) · Journal of Morphological Sciences · doi:10.55302/jms2471171pm

The changes of Coagulation State in Patients Contracted with SARS-COV-19

Nosrati, A. (2020) · Iranian journal of pathology · doi:10.30699/ijp.2020.129354.2427 · Cited by 1

Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

Xiao, M., Zhang, Y., Zhang, S., Qin, X., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41425 · Cited by 174

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang, Y., Cao, W., Jiang, W., Xiao, M., Li, Y., Tang, N., Liu, Z., Yan, X., Zhao, Y., Li, T., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02182-9 · Cited by 162

Evaluation of Antiphospholipid Antibodies in COVID-19 Patients with Coagulopathy.

Nosrati, A., Torabizadeh, Z., Kheirkhah, D., Larijani, L. V., Alizade-Navaei, R., Mobini, M., Aliyali, M., Abedi, S., & Mehravaran, H. (2022) · PubMed Central · Cited by 2